Skip to main content
Toggle navigation
Search
Home
Back
Favorite
0
Like
Facebook
Print
Session I: Opening Session
LBA O-10: First-line panitumumab versus bevacizumab in combination with mFOLFOX6 for RAS wild-type metastatic colorectal cancer: PARADIGM trial results
Wednesday, June 29, 2022
13:15 – 13:25
Location: Auditorium A; Level 0
Abstract Presenter(s)
Kei Muro, MD and PhD
Aichi Cancer Center Hospital
Nagoya, Japan
